Neurological disability: SAFNeR brings experts together to make care more accessible

Author: Adolphe ANGOUAPublished on: November 4, 2026Country: Côte d’Ivoire
Health
Neurological disability: SAFNeR brings experts together to make care more accessible

The third ordinary congress of the Society of Francophone Africa for Neurorehabilitation (SAFNeR) is being held from October 28 to 30, 2026, at Saint-Joseph Moscati Catholic Hospital in Yamoussoukro. Health professionals from numerous disciplines are discussing care for disabilities caused by conditions and injuries including strokes, spinal cord and brain trauma, cerebral palsy, and amputations. Under the patronage of Eugène Aka Aouélé, the gathering aims to strengthen cooperation, update professional knowledge, and encourage national neurorehabilitation programs suited to African countries. Founded in 2021, SAFNeR promotes neurorehabilitation on a scientific basis.

Stay informed with NewsBoulevard

Get the latest news summaries delivered to your inbox

Related News

Methane emissions: Ogun State and federal government intensify investigation in Ijebu-Ode
Environment & ClimateHealthNigeria
dailypost.ng•

Methane emissions: Ogun State and federal government intensify investigation in Ijebu-Ode

Following four gas-emission incidents in Ijebu-Ode and nearby communities, Ogun State has stepped up cooperation with the federal government to identify the source and prevent further occurrences. A team of experts from the Nigerian Upstream Petroleum Regulatory Commission (NUPRC), led by Deputy Director Omonedo Prosper, is examining the emissions with development partners and state officials. The government says it will promptly release the findings, implement the team’s recommendations and provide health monitoring in affected areas, including Ijebu-Ode, Ijebu East and Odogbolu. Professor Ikhane Phillips of Olabisi Onabanjo University said geochemical and geophysical investigations could establish the gas’s composition, source and underground movement.

Read More
Ebola: WHO endorses two new vaccine candidates against Bundibugyo virus
HealthScienceDemocratic Republic of the Congo
AfricaNews•

Ebola: WHO endorses two new vaccine candidates against Bundibugyo virus

The WHO has recommended two vaccine candidates against Bundibugyo virus, which is causing the current Ebola outbreak in the Democratic Republic of the Congo. Oxford University and the Serum Institute of India developed ChAdOx1 BDBV, while Moderna developed mRNA-1469; both are expected to join a clinical trial launched last month alongside Ervebo, which is not approved for this strain. The trial is led by the DRC’s National Institute of Biomedical Research with international partners. Preliminary safety and immunogenicity findings are encouraging, but efficacy still needs to be confirmed; Africa CDC reports 10,444 confirmed cases and more than 5,300 deaths.

Read More

Stay Updated with NewsBoulevard

Subscribe to our newsletter for the latest news summaries delivered to your inbox